29.14
0.02 (0.07%)
0.02 (0.07%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.03 | 0.1% | 29.12 | 28.72 | 29.68 | 29.26 | 29.09 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 29.14 | 29.49 | 0.35 | 1.19% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,045 | 847,826 | $ 29.20 | $ 24,754,014 | 2,876,926 | 17.67 - 42.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:55:02 | formt | 200 | $ 29.14 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 4.26B | 146.34M | 136.47M | $ - | $ - | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.61 | 29.80 | 26.34 | 28.01 | 1,854,807 | 1.51 | 5.47% |
| 1 Month | 31.21 | 33.37 | 26.34 | 29.07 | 2,280,680 | -2.09 | -6.7% |
| 3 Months | 31.45 | 42.00 | 26.34 | 32.57 | 2,170,483 | -2.33 | -7.41% |
| 6 Months | 25.19 | 42.00 | 18.70 | 30.55 | 2,006,327 | 3.93 | 15.6% |
| 1 Year | 24.51 | 42.00 | 17.67 | 27.52 | 1,628,765 | 4.61 | 18.81% |
| 3 Years | 7.35 | 42.00 | 4.45 | 19.33 | 1,266,801 | 21.77 | 296.19% |
| 5 Years | 8.91 | 42.00 | 4.24 | 17.53 | 891,728 | 20.21 | 226.82% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
